Ensign Peak Advisors, Inc Exact Sciences Corp Transaction History
Ensign Peak Advisors, Inc
- $51.2 Billion
- Q1 2025
A detailed history of Ensign Peak Advisors, Inc transactions in Exact Sciences Corp stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 1,219,452 shares of EXAS stock, worth $57.2 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
1,219,452
Previous 1,288,876
5.39%
Holding current value
$57.2 Million
Previous $72.4 Million
27.11%
% of portfolio
0.1%
Previous 0.13%
Shares
22 transactions
Others Institutions Holding EXAS
# of Institutions
642Shares Held
156MCall Options Held
1.64MPut Options Held
1.5M-
Capital World Investors Los Angeles, CA17.8MShares$837 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.6MShares$827 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12.5MShares$586 Million0.11% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$566 Million0.01% of portfolio
-
State Street Corp Boston, MA6.61MShares$310 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $8.3B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...